Primate models of Parkinson's disease

By Collier T.J.   Steece-Collier K.   Kordower J.H.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 258-262

Elsevier

Access to resources Recommend Favorite

Edaravone Prevents Neurotoxicity of Mutant L166P DJ-1 in Parkinson’s Disease

By Li Bing   Yu Dawei   Xu Zhiying  

Journal of Molecular Neuroscience, Vol. 51, Iss. 2, 2013-10 ,pp. : 539-549

Humana Press, Inc

Access to resources Recommend Favorite

- and -Opioid Receptor Antagonists Reduce Levodopa-Induced Dyskinesia in the MPTP-Lesioned Primate Model of Parkinson's Disease

By Henry B.   Fox S.H.   Crossman A.R.   Brotchie J.M.  

Experimental Neurology, Vol. 171, Iss. 1, 2001-09 ,pp. : 139-146

Elsevier

Access to resources Recommend Favorite

Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson’s disease

By Pessiglione M.   Guehl D.   Agid Y.   Hirsch E.C.   Féger J.   Tremblay L.  

Brain, Vol. 126, Iss. 6, 2003-06 ,pp. : 1392-1408

Oxford University Press

Access to resources Recommend Favorite

Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson’s disease?

By Guidez Daniel   Behnke Stefanie   Halmer Ramona   Dillmann Ulrich   Faßbender Klaus   Kirsch Carl   Hellwig Dirk   Spiegel Jörg  

Journal of Neurology, Vol. 261, Iss. 1, 2014-01 ,pp. : 45-51

Springer Publishing Company

Access to resources Recommend Favorite